| 000 | 01736 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250518041411.0 | ||
| 264 | 0 | _c20210114 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a1478-6427 | ||
| 024 | 7 |
_a10.1080/14786419.2019.1610751 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Bang-Yan | |
| 245 | 0 | 0 |
_aInducing secondary metabolite production from _h[electronic resource] |
| 260 |
_bNatural product research _cNov 2020 |
||
| 300 |
_a3101-3107 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _a3T3-L1 Cells |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntifungal Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCholinesterase Inhibitors _xchemistry |
| 650 | 0 | 4 |
_aCulture Media _xpharmacology |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
| 650 | 0 | 4 | _aFermentation |
| 650 | 0 | 4 |
_aFusarium _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLactones _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aPanax _xchemistry |
| 650 | 0 | 4 | _aSecondary Metabolism |
| 650 | 0 | 4 |
_aXylariales _xdrug effects |
| 700 | 1 | _aYang, Ya-Bin | |
| 700 | 1 | _aYang, Xue-Qiong | |
| 700 | 1 | _aZhu, Chen-Hao | |
| 700 | 1 | _aYang, Shuang | |
| 700 | 1 | _aXu, Ting-Ting | |
| 700 | 1 | _aWang, Xue-Yin | |
| 700 | 1 | _aTan, Ning-Hua | |
| 700 | 1 | _aZhou, Hao | |
| 700 | 1 | _aDing, Zhong-Tao | |
| 773 | 0 |
_tNatural product research _gvol. 34 _gno. 21 _gp. 3101-3107 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/14786419.2019.1610751 _zAvailable from publisher's website |
| 999 |
_c29712852 _d29712852 |
||